Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line

Detalhes bibliográficos
Autor(a) principal: Viegas, Juliane Oliveira
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/22356
Resumo: Graphene oxide (GO) is a compound with application in several fields, especially biomedicine and environment, due to its unique properties which confer excellent characteristics. Despite the nowadays wide application of nanomaterials, the lack of information regarding the risks to human health and the environment is still remaining. Consequently, the investigation about the toxicity of nanoparticles must be a priority. The lung is one of the main routes of entry for nanoparticles into the body, therefore, the aim of this study is to evaluate the cytotoxic potential of graphene oxide in lung, using as model the human carcinoma epithelial cell line (A549). The morphology and viability of A549 cells were evaluated after 24h of exposure to GO at concentrations from 10μg/ml to 200μg/ml. The uptake of GO and the production of reactive oxygen species were also investigated by flow cytometry. The results suggest that GO has no obvious toxicity to A549 cells when assessed by WST-8 assay, though the cell cycle showed a slightly alteration in the S and G2 phase at 50μg/mL with arrest at G2 phase. Also, GO showed an increasing in the ROS production at the lowest doses (10ug/mL and 37μg/mL). The intracellular uptake increased for the highest concentration. Together these results suggest that this form of GO shows biocompatibility for lung cells.
id RCAP_2abf2a47a410a9f4c74711d043187bd5
oai_identifier_str oai:ria.ua.pt:10773/22356
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell lineOxido de grafeno - CitotoxicidadeCancro do pulmãoCitometria de fluxoPatologia celularGraphene oxide (GO) is a compound with application in several fields, especially biomedicine and environment, due to its unique properties which confer excellent characteristics. Despite the nowadays wide application of nanomaterials, the lack of information regarding the risks to human health and the environment is still remaining. Consequently, the investigation about the toxicity of nanoparticles must be a priority. The lung is one of the main routes of entry for nanoparticles into the body, therefore, the aim of this study is to evaluate the cytotoxic potential of graphene oxide in lung, using as model the human carcinoma epithelial cell line (A549). The morphology and viability of A549 cells were evaluated after 24h of exposure to GO at concentrations from 10μg/ml to 200μg/ml. The uptake of GO and the production of reactive oxygen species were also investigated by flow cytometry. The results suggest that GO has no obvious toxicity to A549 cells when assessed by WST-8 assay, though the cell cycle showed a slightly alteration in the S and G2 phase at 50μg/mL with arrest at G2 phase. Also, GO showed an increasing in the ROS production at the lowest doses (10ug/mL and 37μg/mL). The intracellular uptake increased for the highest concentration. Together these results suggest that this form of GO shows biocompatibility for lung cells.O óxido de grafeno (GO) é um composto com aplicação em diversas áreas, especialmente biomedicina e ambiente, devido as suas propriedades únicas que lhe conferem excelentes características. Apesar da atual ampla utilização de nanomateriais, a falta de informação sobre os riscos para a saúde humana e para o ambiente ainda permanece. Consequentemente, a investigação sobre a toxicidade das nanopartículas deve ser uma prioridade. Sendo o pulmão uma das principais vias de entrada das nanopartículas no organismo, o objetivo deste trabalho é avaliar o potencial citotóxico de óxido de grafeno no pulmão, usando com modelo uma linha celular epitelial de carcinoma do pulmão humano (A549). A morfologia e a viabilidade das células A549 foram avaliados após 24 horas de exposição a concentrações de GO entre 10μg/mL a 200μg/mL. A captação de GO e a produção de espécies reativas de oxigênio foram avaliadas por citometria de fluxo. Os resultados sugerem que GO não apresenta óbvia toxicidade para as células A549, quando avaliada pelo ensaio WST-8. No entanto, no ciclo celular observou-se uma ligeira alteração na fase S e na fase G2 em 50μg/mL, com paragem na fase G2. GO induziu também um aumento na produção de ROS em doses mais baixas (10μg/mL e 37μg/mL). A captação intracelular de GO aumentou para a dose mais elevada. Em conjunto, estes resultados sugerem que esta forma de GO apresenta biocompatibilidade para as células de pulmão.Universidade de Aveiro2016-12-162016-12-16T00:00:00Z2018-12-10T10:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/22356TID:201936585engViegas, Juliane Oliveirainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:43:51Zoai:ria.ua.pt:10773/22356Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:56:31.563337Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
title Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
spellingShingle Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
Viegas, Juliane Oliveira
Oxido de grafeno - Citotoxicidade
Cancro do pulmão
Citometria de fluxo
Patologia celular
title_short Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
title_full Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
title_fullStr Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
title_full_unstemmed Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
title_sort Cytotoxic potential of graphene oxide in human lung Adenocarcinoma cell line
author Viegas, Juliane Oliveira
author_facet Viegas, Juliane Oliveira
author_role author
dc.contributor.author.fl_str_mv Viegas, Juliane Oliveira
dc.subject.por.fl_str_mv Oxido de grafeno - Citotoxicidade
Cancro do pulmão
Citometria de fluxo
Patologia celular
topic Oxido de grafeno - Citotoxicidade
Cancro do pulmão
Citometria de fluxo
Patologia celular
description Graphene oxide (GO) is a compound with application in several fields, especially biomedicine and environment, due to its unique properties which confer excellent characteristics. Despite the nowadays wide application of nanomaterials, the lack of information regarding the risks to human health and the environment is still remaining. Consequently, the investigation about the toxicity of nanoparticles must be a priority. The lung is one of the main routes of entry for nanoparticles into the body, therefore, the aim of this study is to evaluate the cytotoxic potential of graphene oxide in lung, using as model the human carcinoma epithelial cell line (A549). The morphology and viability of A549 cells were evaluated after 24h of exposure to GO at concentrations from 10μg/ml to 200μg/ml. The uptake of GO and the production of reactive oxygen species were also investigated by flow cytometry. The results suggest that GO has no obvious toxicity to A549 cells when assessed by WST-8 assay, though the cell cycle showed a slightly alteration in the S and G2 phase at 50μg/mL with arrest at G2 phase. Also, GO showed an increasing in the ROS production at the lowest doses (10ug/mL and 37μg/mL). The intracellular uptake increased for the highest concentration. Together these results suggest that this form of GO shows biocompatibility for lung cells.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-16
2016-12-16T00:00:00Z
2018-12-10T10:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/22356
TID:201936585
url http://hdl.handle.net/10773/22356
identifier_str_mv TID:201936585
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de Aveiro
publisher.none.fl_str_mv Universidade de Aveiro
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137619235307520